Pages that link to "Q48277563"

The following pages link to Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia (Q48277563):

Displaying 42 items.

• A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue (Q26770756) (← links)
• Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders (Q26784904) (← links)
• Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia (Q28240120) (← links)
• Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. (Q30387014) (← links)
• Phenotypic characterization of mice heterozygous for a null mutation of glutamate carboxypeptidase II. (Q30480306) (← links)
• What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia (Q30597641) (← links)
• Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia (Q33448981) (← links)
• Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects (Q33503890) (← links)
• Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. (Q33762408) (← links)
• Diffusion tensor imaging study of the fornix in first episode schizophrenia and in healthy controls. (Q33842103) (← links)
• White matter tract abnormalities between rostral middle frontal gyrus, inferior frontal gyrus and striatum in first-episode schizophrenia (Q33949733) (← links)
• White matter abnormalities in schizophrenia and schizotypal personality disorder (Q34701041) (← links)
• Maternal serum docosahexaenoic acid and schizophrenia spectrum disorders in adult offspring (Q34899136) (← links)
• A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression (Q35014891) (← links)
• Multimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis use (Q35019147) (← links)
• Extensive white matter abnormalities in patients with first-episode schizophrenia: a Diffusion Tensor Iimaging (DTI) study (Q35162732) (← links)
• Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism (Q35203647) (← links)
• Accumulation of N-Acylphosphatidylserines and N-Acylserines in the Frontal Cortex in Schizophrenia (Q35776132) (← links)
• Use of T1-weighted/T2-weighted magnetic resonance ratio images to elucidate changes in the schizophrenic brain. (Q36186550) (← links)
• Frontal lobe alterations in schizophrenia: a review (Q36246546) (← links)
• Magnetic resonance imaging of myelin (Q36864333) (← links)
• Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. (Q36955877) (← links)
• Transcriptional correlates of human substance use. (Q36995678) (← links)
• Metabolomics: a global biochemical approach to the study of central nervous system diseases (Q37289766) (← links)
• Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies (Q37317859) (← links)
• Molecular profiles of schizophrenia in the CNS at different stages of illness. (Q37439158) (← links)
• Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy (Q37546096) (← links)
• Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists (Q37775612) (← links)
• Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis (Q37810163) (← links)
• Regulation and roles of neuronal diacylglycerol kinases: a lipid perspective (Q37871598) (← links)
• NAAG, NMDA receptor and psychosis (Q37981289) (← links)
• Finding the needle in the haystack: a review of microarray gene expression research into schizophrenia (Q37996281) (← links)
• The QKI-PLP pathway controls SIRT2 abundance in CNS myelin (Q39137544) (← links)
• A brain proteomic investigation of rapamycin effects in the Tsc1+/- mouse model (Q41211684) (← links)
• Low Density Lipoprotein Receptor-Related Protein and Apolipoprotein E Expression is Altered in Schizophrenia (Q41771932) (← links)
• Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study (Q41818539) (← links)
• Magnetic Resonance of Myelin Water: An in vivo Marker for Myelin. (Q55006976) (← links)
• (Q55886604) (redirect page) (← links)
• Pharmacotherapy of schizophrenia: toward a metabolomic-based approach (Q88982667) (← links)
• Metabolomics in Psychiatric Disorders: What We Learn from Animal Models (Q89805466) (← links)
• Altered expression of microRNA-223 in the plasma of patients with first-episode schizophrenia and its possible relation to neuronal migration-related genes (Q91235044) (← links)
• Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients (Q91622024) (← links)